OPF-310A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Sponsor:

Otsuka Pharmaceutical Factory, Inc.

Code:

NCT06575426

Conditions

Diabetes Mellitus, Type 1

Hypoglycemia

Islet Cell Transplantation

Type 1 Diabetes

Type 1 Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 35 - 70

Healthy Volunteers: Not accepted

Interventions

OPF-310

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Otsuka Pharmaceutical Factory, Inc. on 2026-08-21.